Clinical Trial

Danish Pragmatic Randomized Trial to Evaluate the Effect of HeartLogic-Guided Management on Heart Failure Outcomes

Study acronym: DANLOGIC-HF
Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of the study is to assess the impact of HeartLogic-guided management on clinical outcomes among patients implanted with an eligible cardiac device.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-10-19; most recent amendment 2025-09-08.
Status change: Not Yet Recruiting → Recruiting 2024-07-08
Trial Details
NCT Number NCT06099158
Lead Sponsor Tor Biering-Sørensen
Collaborators: Boston Scientific Corporation
Conditions Heart Failure
Enrollment 1,428 participants
Start Date 2024-05-31
Primary Completion 2027-12-01 (estimated)
Study Completion 2027-12-01 (estimated)
Updated on ClinicalTrials.gov 2025-09-12